Global Financial Private Capital’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Global Financial Private Capital’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-31,310	Closed	-$674K	–	499
2018 Q3	$674K	Buy	31,310 +7,678	+32%	+$178K	0.02%	332
2018 Q2	$575K	Buy	23,632 +11,335	+92%	+$231K	0.02%	344
2018 Q1	$210K	Buy	12,297 +2,115	+21%	+$41.3K	0.01%	499
2017 Q4	$193K	Buy	+10,182	New	+$153K	0.01%	490

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

Brahman Capital New York $275M AUM 18.08% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Global Financial Private Capital's TEVA Position: Q4 2018 in Review

Global Financial Private Capital sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2018, closing a stake of 31,310 shares — an estimated $674K sold.

Global Financial Private Capital first reported a position in TEVA in Q4 2017 and held it in 4 quarters. The position peaked at $674K in Q3 2018. 552 funds tracked by Wall St. Rank hold TEVA as of Q4 2018.

Global Financial Private Capital reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2018 after selling out during the quarter.
Global Financial Private Capital sold 31,310 Teva Pharmaceutical Industries Limited shares in Q4 2018, an estimated $674K.
Global Financial Private Capital first reported a position in Teva Pharmaceutical Industries Limited in Q4 2017 and held it in 4 quarters.
Global Financial Private Capital's Teva Pharmaceutical Industries Limited position peaked at $674K in Q3 2018.
552 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2018.

Based on Global Financial Private Capital's 13F filing for Q4 2018, filed 5 Feb 2019.